{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:31:37Z","timestamp":1793946697018,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.diabres.2026.113291","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:58:11Z","timestamp":1777841891000},"page":"113291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gut microbiota-mediated metabolic dysregulation in type 2 diabetes and metabolic syndrome: emerging therapeutic targets beyond glycaemic control"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-0290","authenticated-orcid":false,"given":"Himanshu","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryakant","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind Sharad","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113291_b0005","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2026.113291_b0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13679-019-00352-2","article-title":"Understanding the role of the gut microbiome and microbial metabolites in obesity and obesity-associated metabolic disorders: current evidence and perspectives","volume":"8","author":"Vallianou","year":"2019","journal-title":"Curr Obes Rep"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM","volume":"15","author":"Canfora","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nature Review Immunology"},{"issue":"3","key":"10.1016\/j.diabres.2026.113291_b0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12020-019-02103-8","article-title":"Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications","volume":"66","author":"Zhao","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.diabres.2026.113291_b0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","article-title":"Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans","volume":"164","author":"Sender","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur J Nutr"},{"issue":"6","key":"10.1016\/j.diabres.2026.113291_b0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0050","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun"},{"issue":"6380","key":"10.1016\/j.diabres.2026.113291_b0055","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"issue":"7228","key":"10.1016\/j.diabres.2026.113291_b0060","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2026.113291_b0065","doi-asserted-by":"crossref","unstructured":"Cryan, J. F., O\u2019Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., et al. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877\u20132013. https:\/\/doi.org\/10.1152\/physrev.00018.2018.","DOI":"10.1152\/physrev.00018.2018"},{"key":"10.1016\/j.diabres.2026.113291_b0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fimmu.2014.00427","article-title":"The intestinal microbiome in early life: health and disease","volume":"5","author":"Arrieta","year":"2014","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113291_b0075","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.diabres.2026.113291_b0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chom.2020.01.006","article-title":"Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production","volume":"27","author":"Deehan","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0085","doi-asserted-by":"crossref","first-page":"e02566","DOI":"10.1128\/mBio.02566-18","article-title":"Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers","volume":"10","author":"Baxter","year":"2019","journal-title":"MBio"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0090","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAD-0019-2017","article-title":"Modulation of the gastrointestinal microbiome with nondigestible fermentable carbohydrates to improve human health","volume":"5","author":"Deehan","year":"2017","journal-title":"Microbiol Spectrum"},{"key":"10.1016\/j.diabres.2026.113291_b0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000475736","article-title":"Enteroendocrine cells: Metabolic relays between microbes and their host","volume":"32","author":"Plovier","year":"2017","journal-title":"Endocr Dev"},{"issue":"11","key":"10.1016\/j.diabres.2026.113291_b0100","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307913","article-title":"Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults","volume":"64","author":"Chambers","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.diabres.2026.113291_b0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0110","first-page":"1","article-title":"Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)","volume":"66","author":"Ratajczak","year":"2019","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113291_b0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2026.113291_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103293","article-title":"Short chain fatty acids and its producing organisms: an overlooked therapy for IBD?","volume":"66","author":"Deleu","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","article-title":"Role of bile acids in metabolic control","volume":"29","author":"Molinaro","year":"2018","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/j.diabres.2026.113291_b0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diabres.2026.113291_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2019_238","article-title":"The pharmacology of bile acids and their receptors","volume":"256","author":"Fiorucci","year":"2019","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113291_b0140","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cmet.2018.07.001","article-title":"Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome","volume":"28","author":"Natividad","year":"2018","journal-title":"Cell Metab"},{"issue":"6382","key":"10.1016\/j.diabres.2026.113291_b0150","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.diabres.2026.113291_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.diabres.2026.113291_b0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41575-018-0025-6","article-title":"Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer","volume":"15","author":"Cani","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2026.113291_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0170","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1159\/000534872","article-title":"The Intersection between bacterial metabolism and innate immunity","volume":"15","author":"Acosta","year":"2023","journal-title":"J Innate Immun"},{"issue":"8","key":"10.1016\/j.diabres.2026.113291_b0175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113291_b0180","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41575-021-00430-8","article-title":"AHR in the intestinal microenvironment: safeguarding barrier function","volume":"18","author":"Stockinger","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113291_b0185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113291_b0190","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/gutjnl-2021-324053","article-title":"Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies","volume":"71","author":"Qi","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-018-0061-2","article-title":"You are what you eat: diet, health and the gut microbiota","volume":"16","author":"Zmora","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.diabres.2026.113291_b0200","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.diabres.2026.113291_b0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"issue":"16","key":"10.1016\/j.diabres.2026.113291_b0210","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","article-title":"Gut-microbiota-targeted diets modulate human immune status","volume":"184","author":"Wastyk","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.diabres.2026.113291_b0215","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MCO.0000000000000849","article-title":"Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine","volume":"25","author":"Perez-Diaz-Del-Campo","year":"2022","journal-title":"Current Opinion in Clinical Nutrition & Metabolic Care"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","article-title":"Microbial regulation of organismal energy homeostasis","volume":"1","author":"Cani","year":"2019","journal-title":"Nature Metabolism"},{"issue":"6","key":"10.1016\/j.diabres.2026.113291_b0230","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.chom.2022.04.016","article-title":"Rethinking healthy eating in light of the gut microbiome","volume":"30","author":"Armet","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.diabres.2026.113291_b0235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113291_b0240","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.diabres.2026.113291_b0245","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.diabres.2026.113291_b0250","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2021.10.029","article-title":"Non-invasive evaluation of response to obeticholic acid in patients with NASH: results from the REGENERATE study","volume":"76","author":"Rinella","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0255","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","article-title":"Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis","volume":"79","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113291_b0260","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/med.21991","article-title":"FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid","volume":"44","author":"Wang","year":"2024","journal-title":"Med Res Rev"},{"issue":"3","key":"10.1016\/j.diabres.2026.113291_b0265","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2021.10.018","article-title":"EDP-305 in patients with NASH: a phase II double-blind placebo-controlled dose-ranging study","volume":"76","author":"Ratziu","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0270","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small-molecule inhibitor of NLRP3 inflammasome, attenuates colonic inflammation in mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0275","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"10","key":"10.1016\/j.diabres.2026.113291_b0280","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","article-title":"Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms","volume":"19","author":"Cani","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113291_b0290","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jat.4044","article-title":"Toxicological safety evaluation of pasteurized Akkermansia muciniphila","volume":"41","author":"Druart","year":"2021","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.diabres.2026.113291_b0295","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3389\/fimmu.2019.01341","article-title":"Fecal microbial transplantation and its potential application in cardiometabolic syndrome","volume":"10","author":"Leshem","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.diabres.2026.113291_b0300","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0305","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chom.2023.03.020","article-title":"Key determinants of success in fecal microbiota transplantation: from microbiome to clinic","volume":"31","author":"Porcari","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"7889","key":"10.1016\/j.diabres.2026.113291_b0310","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","article-title":"Combinatorial, additive and dose-dependent drug\u2013microbiome associations","volume":"600","author":"Forslund","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0315","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vila","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1757-4749-4-16","article-title":"Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes","volume":"4","author":"Saad","year":"2012","journal-title":"Gut Pathogens"},{"issue":"7762","key":"10.1016\/j.diabres.2026.113291_b0325","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0330","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2891-13-60","article-title":"Gut microbiota, probiotics and diabetes","volume":"13","author":"Gomes","year":"2014","journal-title":"Nutr J"},{"issue":"5","key":"10.1016\/j.diabres.2026.113291_b0335","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.diabres.2026.113291_b0340","article-title":"Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment","volume":"7","author":"Ahmed","year":"2025","journal-title":"Front Med Technol"},{"issue":"477","key":"10.1016\/j.diabres.2026.113291_b0345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw1815","article-title":"Transforming medicine with the microbiome","volume":"11","author":"Zmora","year":"2019","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113291_b0350","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","article-title":"Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT","volume":"174","author":"Suez","year":"2018","journal-title":"Cell"},{"issue":"7695","key":"10.1016\/j.diabres.2026.113291_b0355","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.diabres.2026.113291_b0360","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2015.07.007","article-title":"Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome","volume":"22","author":"Ussar","year":"2015","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113291_b0365","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2020","journal-title":"Nat Rev Microbiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:57:39Z","timestamp":1793944659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726002111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"alternative-id":["S0168822726002111"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113291","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota-mediated metabolic dysregulation in type 2 diabetes and metabolic syndrome: emerging therapeutic targets beyond glycaemic control","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113291"}}